Skip to content
DraconiticResearch
Search Sources API
220,430 studies31 sourcesUpdated 30 min ago
Peer-reviewedCC BY 4.0Frontiers in Oncology

Exploring the trajectory of quality-of-life deterioration associated with capecitabine-induced hand-foot syndrome and the optimal timing for rehabilitation intervention: secondary analysis of a randomized controlled trial

Abstract

ObjectiveTo investigate the dynamic progression and key turning points of quality-of-life (QoL) impairment in patients with capecitabine-induced hand-foot syndrome (HFS) and identify the optimal timing for rehabilitation intervention.MethodsThis secondary analysis included 234 breast cancer patients receiving capecitabine from a multicenter, double-blind randomized controlled trial. HFS-related QoL (HF-QoL), EORTC QLQ-C30, and QLQ-BR23 were assessed longitudinally. Generalized estimating equations examined HFS grade-by-time interactions, and clinically significant deterioration was defined using the minimum clinically important difference (MCID ≥10 points).ResultsSignificant HFS grade-by-time interactions were observed for HF-QoL (β=1.215, 95% CI = [0.689, 1.741], P < 0.001), QLQ-C30 (β=1.464, 95% CI = [0.820, 2.109], P < 0.001), and QLQ-BR23 (β=0.451, 95% CI = [0.148,0.753], P = 0.004), indicating accelerated QoL deterioration with increasing HFS severity. The proportion of patients with clinically significant HF-QoL deterioration increased sharply from Grade 1 to Grade 2 (18.9% vs. 41.9%; OR = 3.053, P = 0.010).ConclusionHFS severity and QoL deterioration show divergent trajectories; Grade 2 may represent a critical threshold at which QoL impairment crosses the threshold of clinical significance; progression from HFS Grade 1 to Grade 2 may be a potential time point for validation in future prospective rehabilitation intervention studies.

Related

  1. Emotional Improvement Despite General Clinical Deterioration During Multidisciplinary Rehabilitation in Stiff Person Syndrome: A Longitudinal Case Report
    Marianna Contrada, Federica Scarfone, Martina Vatrano +7
    Clinical case reportsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  2. Perineural invasion is associated with an aggressive phenotype and reduced in vitro capecitabine sensitivity in colorectal cancer
    Shuzhe Yang, Zhongyuan Bai, Yanan Li +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  3. Evaluating the functional impact of yoga-based cardiac rehabilitation following percutaneous coronary intervention
    Gautam Sharma, Nayani Makkar, Sriloy Mohanty +7
    BMC MedicinePeer-reviewedCC BY-NC-ND 4.0Cardiovascular medicineCrossref
  4. Digital training to support delivery of an evidence-based cardiac rehabilitation programme for heart failure: a mixed-methods evaluation of healthcare professionals' training experiences and intervention fidelity.
    Samantha B Van Beurden, Rosina Cross, Sinead Tj McDonagh +7
    BMJ openPeer-reviewedCC BYFull textGeneral medicineEurope PMCCrossref
  5. A longitudinal study on the developmental trajectory and interaction between learned helplessness and adherence with rehabilitation exercises in hemiplegic patients following a stroke
    Xiaoyan Sheng, Li Feng, Zheng Jiang +1
    Frontiers in NeurologyPeer-reviewedCC BY 4.0NeurologyCrossref
BibTeX
@article{wang2026exploring,
  title = {{Exploring the trajectory of quality-of-life deterioration associated with capecitabine-induced hand-foot syndrome and the optimal timing for rehabilitation intervention: secondary analysis of a randomized controlled trial}},
  author = {Yujing Wang and Weilin Yin and Jie Zhang and Yifan Lin and Jie Jia},
  journal = {Frontiers in Oncology},
  year = {2026},
  month = nov,
  doi = {10.3389/fonc.2026.1988890},
  url = {https://www.frontiersin.org/articles/10.3389/fonc.2026.1988890},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Exploring the trajectory of quality-of-life deterioration associated with capecitabine-induced hand-foot syndrome and the optimal timing for rehabilitation intervention: secondary analysis of a randomized controlled trial
AU  - Yujing Wang
AU  - Weilin Yin
AU  - Jie Zhang
AU  - Yifan Lin
AU  - Jie Jia
PY  - 2026
DA  - 2026/11/12
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2026.1988890
UR  - https://www.frontiersin.org/articles/10.3389/fonc.2026.1988890
AB  - ObjectiveTo investigate the dynamic progression and key turning points of quality-of-life (QoL) impairment in patients with capecitabine-induced hand-foot syndrome (HFS) and identify the optimal timing for rehabilitation intervention.MethodsThis secondary analysis included 234 breast cancer patients receiving capecitabine from a multicenter, double-blind randomized controlled trial. HFS-related QoL (HF-QoL), EORTC QLQ-C30, and QLQ-BR23 were assessed longitudinally. Generalized estimating equations examined HFS grade-by-time interactions, and clinically significant deterioration was defined using the minimum clinically important difference (MCID ≥10 points).ResultsSignificant HFS grade-by-time interactions were observed for HF-QoL (β=1.215, 95% CI = [0.689, 1.741], P < 0.001), QLQ-C30 (β=1.464, 95% CI = [0.820, 2.109], P < 0.001), and QLQ-BR23 (β=0.451, 95% CI = [0.148,0.753], P = 0.004), indicating accelerated QoL deterioration with increasing HFS severity. The proportion of patients with clinically significant HF-QoL deterioration increased sharply from Grade 1 to Grade 2 (18.9% vs. 41.9%; OR = 3.053, P = 0.010).ConclusionHFS severity and QoL deterioration show divergent trajectories; Grade 2 may represent a critical threshold at which QoL impairment crosses the threshold of clinical significance; progression from HFS Grade 1 to Grade 2 may be a potential time point for validation in future prospective rehabilitation intervention studies.
SN  - 2234-943X
ER  -